Literature DB >> 29868970

Does this patient with thrombotic thrombocytopenic purpura have a cardiac involvement?

Lara Zafrani1, Lene Russell2,3, Elie Azoulay4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29868970     DOI： 10.1007/s00134-018-5243-4

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  19 in total

Review 1.  Thrombotic microangiopathies.

Authors:  Joel L Moake
Journal:  N Engl J Med       Date:  2002-08-22       Impact factor: 91.245

2.  Predictors of in-hospital mortality and acute myocardial infarction in thrombotic thrombocytopenic purpura.

Authors:  Nivas Balasubramaniyam; Dhaval Kolte; Chandrasekar Palaniswamy; Kiran Yalamanchili; Wilbert S Aronow; John A McClung; Sahil Khera; Sachin Sule; Stephen J Peterson; William H Frishman
Journal:  Am J Med       Date:  2013-08-29       Impact factor: 4.965

3.  Incidence and prognosis of acute heart failure in the thrombotic microangiopathies.

Authors:  Apoor S Gami; Suzanne R Hayman; Joseph P Grande; Vesna D Garovic
Journal:  Am J Med       Date:  2005-05       Impact factor: 4.965

4.  An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries (Moschcowitz 1925).

Authors:  M C Brain
Journal:  Thromb Haemost       Date:  1978-08-31       Impact factor: 5.249

5.  Takotsubo cardiomyopathy and thrombotic thrombocytopenic purpura preceding a lupus diagnosis: a case report.

Authors:  F Georgiades; S Demosthenous; M Braimi; T Tsitskari; S Psarelis
Journal:  Lupus       Date:  2015-06-30       Impact factor: 2.911

Review 6.  Plasma ADAMTS-13 levels and the risk of myocardial infarction: an individual patient data meta-analysis.

Authors:  A Maino; B Siegerink; L A Lotta; J T B Crawley; S le Cessie; F W G Leebeek; D A Lane; G D O Lowe; F Peyvandi; F R Rosendaal
Journal:  J Thromb Haemost       Date:  2015-07-14       Impact factor: 5.824

7.  Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.

Authors:  Flora Peyvandi; Marie Scully; Johanna A Kremer Hovinga; Spero Cataland; Paul Knöbl; Haifeng Wu; Andrea Artoni; John-Paul Westwood; Magnus Mansouri Taleghani; Bernd Jilma; Filip Callewaert; Hans Ulrichts; Christian Duby; Dominique Tersago
Journal:  N Engl J Med       Date:  2016-02-11       Impact factor: 91.245

Review 8.  Thrombotic thrombocytopenic purpura.

Authors:  Bérangère S Joly; Paul Coppo; Agnès Veyradier
Journal:  Blood       Date:  2017-04-17       Impact factor: 22.113

9.  The heart and cardiac conduction system in thrombotic thrombocytopenic purpura. A clinicopathologic study of 17 autopsied patients.

Authors:  R L Ridolfi; G M Hutchins; W R Bell
Journal:  Ann Intern Med       Date:  1979-09       Impact factor: 25.391

Review 10.  Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities. A review of 56 autopsy cases.

Authors:  Gregory A Hosler; Ana M Cusumano; Grover M Hutchins
Journal:  Arch Pathol Lab Med       Date:  2003-07       Impact factor: 5.534
View more
  2 in total

1.  Acute dilated cardiomyopathy in the setting of catastrophic antiphospholipid syndrome and thrombotic microangiopathy: A case series and review.

Authors:  Melody Hermel; David Hermel; Saif Azam; Jerold Shinbane; Annahita Sarcon; Erika Jones; Arjun Mehta; Luanda Grazette; Howard Liebman; Ilene Weitz
Journal:  EJHaem       Date:  2020-07-31

2.  Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura.

Authors:  X Long Zheng; Sara K Vesely; Spero R Cataland; Paul Coppo; Brian Geldziler; Alfonso Iorio; Masanori Matsumoto; Reem A Mustafa; Menaka Pai; Gail Rock; Lene Russell; Rawan Tarawneh; Julie Valdes; Flora Peyvandi
Journal:  J Thromb Haemost       Date:  2020-09-11       Impact factor: 5.824
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.